Ausun Pharm released its semi-annual performance report, with a net profit attributable to the parent company of 169 million yuan, a year-on-year decrease of 5.83%

According to the Zhitong Finance APP, Ausun Pharm disclosed its semi-annual report for 2025. During the reporting period, the company achieved revenue of 482 million yuan, a year-on-year decrease of 2.14%; net profit attributable to the parent company was 169 million yuan, a year-on-year decrease of 5.83%; net profit excluding non-recurring gains and losses was 151 million yuan, a year-on-year decrease of 12.29%; basic earnings per share were 0.20 yuan